browse Browse

pac.dog pac.dog / Lobbying

1st Quarter - Report · 2026

Filing UUID
4e41c51e-97ce-49ac-9796-ade0e0839ed2
Type
Q1 — 1st Quarter - Report
Period
first_quarter
Year
2026
Posted
2026-04-20 19:36:09
Income (reported)
$80,000
Expenses (reported)
Filing document
Open on lda.senate.gov
Registrant (lobbying firm)

TODD STRATEGY GROUP

​Government Affairs Consulting Firm.

Contact
BETH ANNE COLE
Phone
+1 202-352-7761
Address
zip:20005, city:Washington, state:DC, street:1201 New York Avenue, NW 8th Floor
Client

ASTRAZENECA PHARMACEUTICALS LP

​Biopharmaceutical Company.

State
DE
Country
US
Government-entity client
false
Effective date
2019-01-01
Issues lobbied + lobbyists (2)

MMM — Medicare/Medicaid

340B Program. Home Infusion for Part B Products. S.864: HELP Copays Act. Medicare Reimbursement for New Technologies.

Lobbyists:
  • ERIC BERGREN — covered position: Chief of Staff, Rep. Brett Guthrie; Staff Assistant, Legislative Correspondent, Legislative Assistant, Senior Legislative Assistant, Legislative Director, Chief of Staff - Rep. Ron Lewis; Intern, Rep. Bill Baker
  • KATHERINE FLEMING COTTON — covered position: Staff Assistant, Legislative Correspondent, Legislative Assistant - U.S. Representative Brett Guthrie
  • PAUL EDATTEL — covered position: Chief Health Counsel, House Energy & Commerce Committee; Policy Assistant, Office of the Speaker; Professional Staff Member for the Majority at the House Energy & Commerce Committee; Legislative Assistant & Legislative Director, Rep. John Shadegg
  • TED LEHMAN — covered position: Chief of Staff, Senator Tillis; Senate Judiciary Committee-Counsel, then Chief Counsel for Nominations and Senior Counsel; Senate Judiciary Committee-Staff Assistant and Legislative Assistant
  • DANIEL M TODD — covered position: Senior Health Counsel, Senate Finance Committee; Special Assistant, Office of Admin. Ct. - Medicare & Medicaid

Government entities lobbied: Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; SENATE; White House Office

HCR — Health Issues

Pediatric Priority Review Voucher Program. General issues related to rare disease and orphan drugs. Diagnostics for patients with rare disease. Multi-Cancer Early Detection. H.R.1672: Maintaining Investments in New Innovation Act. H.R.946: ORPHAN Cures Act. Prescription drug pricing policy.

Lobbyists:

Government entities lobbied: HOUSE OF REPRESENTATIVES; SENATE; White House Office

pac.dog is a free, independent, non-partisan research tool. Every candidate, committee, bill, vote, member, and nonprofit on this site is mirrored from primary U.S. government sources (FEC, congress.gov, govinfo.gov, IRS) and each state's Secretary of State / election commission — no third-party data vendors, no paywall, no editorial intermediation. Citations to the originating source are on every detail page.